Distribution of arylamine N-acetyltransferase (NAT2) genotypes among Omani Arabs.

被引:0
|
作者
Tanira, MOM
Simsek, M
Al Baloushi, K
Al Lawatia, K
Al Barawani, H
Bayoumi, R
机构
[1] Sultan Qaboos Univ, Coll Med, Dept Pharmacol, Al Khod 123, Oman
[2] Sultan Qaboos Univ, Coll Med, Dept Biochem, Al Khod 123, Oman
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
1
引用
收藏
页码:1874 / 1874
页数:1
相关论文
共 50 条
  • [1] Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population
    Aynacioglu, AS
    Cascorbi, I
    Mrozikiewicz, PM
    Roots, I
    PHARMACOGENETICS, 1997, 7 (04): : 327 - 331
  • [2] Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility
    Varzim, G
    Monteiro, E
    Silva, R
    Pinheiro, C
    Lopes, C
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2002, 64 (03): : 206 - 212
  • [3] Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases
    Zielinska, E
    Niewiarowski, W
    Bodalski, J
    Stanczyk, A
    Bolanowski, W
    Rebowski, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (06) : 635 - 642
  • [4] Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers
    Jourenkova-Mironova, N
    Wikman, H
    Bouchardy, C
    Mitrunen, K
    Dayer, P
    Benhamou, S
    Hirvonen, A
    PHARMACOGENETICS, 1999, 9 (04): : 533 - 537
  • [5] N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk
    Bouchardy, C
    Mitrunen, K
    Wikman, H
    Husgafvel-Pursiainen, K
    Dayer, P
    Benhamou, S
    Hirvonen, A
    PHARMACOGENETICS, 1998, 8 (04): : 291 - 298
  • [6] Generation and functional characterization of arylamine N-acetyltransferase NAT1/NAT2 knockout mice
    Sugamori, KS
    Wong, S
    Rozmahel, R
    Grant, DM
    DRUG METABOLISM REVIEWS, 2003, 35 : 143 - 143
  • [7] NUCLEOTIDE-SEQUENCE OF RABBIT NAT2 ENCODING POLYMORPHIC LIVER ARYLAMINE N-ACETYLTRANSFERASE (NAT)
    BLUM, M
    HEIM, M
    MEYER, UA
    NUCLEIC ACIDS RESEARCH, 1990, 18 (17) : 5295 - 5295
  • [8] Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis
    K. Skrętkowicz
    J. Skrętkowicz
    B. Gawrońska-Szklarz
    W. Górnik
    M. Rychlik-Sych
    A. Sysa-Jędrzejowska
    European Journal of Clinical Pharmacology, 2005, 60 : 773 - 778
  • [9] Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis
    Skretkowicz, K
    Skretkowicz, J
    Gawronska-Szklarz, B
    Górnik, W
    Rychlik-Sych, M
    Sysa-Jedrzejowska, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (11) : 773 - 778
  • [10] N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer
    Alberg, AJ
    Daudt, A
    Huang, HY
    Hoffman, SC
    Comstock, GW
    Helzlsouer, KJ
    Strickland, PT
    Bell, DA
    CANCER DETECTION AND PREVENTION, 2004, 28 (03): : 187 - 193